As oncology engages in value-based reimbursement, new payment models, and precision medicine, oncology pharmacists and pharmacy staff are integral to successful delivery of quality, cost-effective patient care.
The challenges are ongoing: increasing complexity of treatment regimens, new drug approvals and indications, the expansion of biosimilars in oncology, rapid advances in immunotherapy, the high cost of cancer treatment, and continual regulatory and reimbursement changes.
The ACCC Oncology Pharmacy Education Network (OPEN) brings together education, resources, and peer-to-peer networking to help pharmacy professionals surmount the challenges and succeed. OPEN offers the knowledge and know-how to navigate the accelerating course of change in oncology—clinically, operationally, fiscally, and programmatically. From USP <800> to integration of biosimilars, from preauthorizations to strategic planning—OPEN addresses real-world oncology pharmacy management issues such as reimbursement, distribution, inventory management, and effective integration of oral oncolytics, biosimilars, and immunotherapies for cancer.
The ACCC Oncology Pharmacy Education Network (OPEN) is seeking a multidisciplinary group of volunteers to serve in various leadership roles, including on the expert advisory committee which leads the initiative, as well as on mission-driven task-forces. Some positions require less time commitment than others, with an average commitment of 1-2 hours per quarter. The target dates of service range from the end of 2020 through 2022.
The deadline to submit your application is Friday, November 5. We greatly appreciate your commitment to improving oncology pharmacy education and look forward to reading your entry.
Miami Cancer Institute shares their unique approach to helping patients with cancer understand why biosimilars may be their best—and most cost-effective—option for treatment.
Learn about the ways cancer programs are working to reduce drug waste and curb the rising cost of cancer care.
We explore how the COVID-19 pandemic has affected patient access to oral oncolytics, and what cancer teams can do to help their patients.
Discover the results of the 2019 Trending Now in Cancer Care Survey—what tops the list of challenges, what areas are trending towards growth, and how cancer programs are evolving to meet the demands of 21st-century cancer care delivery.
Evaluating Pharmacy Dispensing Models to Help Improve Cancer Care Delivery
Biosimilars Education Center
Perspectives on Step Therapy in Oncology
Steps to Success: Implementing Oral Oncolytics
Oral Therapies: A Patient-Centered Approach
Patient-Centered Scheduling: Costs & Benefits of Extending Practice Hours
This special report from ACCC examines the pros and cons of extended infusion suite hours. Included is a tool to help practices and programs assess the feasibility of extending hours of care.
Dispensing Pharmacy Patient Education Tool
Physician dispensing is governed by state law and regulated by State Boards of Pharmacy. While some states do not allow physician dispensing, most of the states that allow it require dispensing physicians to alert their patients about other options to fill their prescription(s). In response to this need, ACCC has developed this patient education tool that can be used across care settings.
Association of Community Cancer Centers Announces October Virtual Learning Series for Pharmacists.
The Importance of the ACCC's Focus on Compensation With Ali McBride as President:
ACCC Marks 15th Anniversary of Oncology Pharmacy Education Network; Honors Founding Leaders
Accelerating Biosimilar Uptake in the US Market: Barriers and Solutions
Access ACCC's comprehensive resource for coding, billing, and reimbursement for oncology drugs.
Access the Database
Need Financial Assistance Resources? Visit the Financial Advocacy Network